EGO-COMBO Clinical End-point Extension Study Beyond 36 Months
NCT02263313
·
clinicaltrials.gov ↗
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Coronary Restenosis
Interventions
OTHER:
EGO-COMBO group
Sponsor
The University of Hong Kong